It doesn't look as though we'll break through 1.25 before cfda approval. Expect a big gap up when it does though.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025